Guest guest Posted April 2, 2006 Report Share Posted April 2, 2006 University Hospital in San plans a trial of Vasopressin. The drug is thought to help survival rates for patients suffering hemorrhagic shock after a bad injury.Drug studies typically require patient consent, but many patients in shock are unconscious. For this study, the patients may be given the drug and then notified when they wake up -- a method known as " deferred consent. " The Food and Drug Administration has granted the trial. <http://www.team4news.com/Global/story.asp?S=4707000 & nav=0w0v> Pray the ry ---------- No virus found in this outgoing message. Checked by AVG Free Edition. Version: 7.1.385 / Virus Database: 268.3.4/299 - Release Date: 3/31/2006 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.